Fatemeh Ezzati, MD
Basic profileThe University of Texas Southwestern Medical Center
Fatemeh Ezzati is a Rheumatology/Immunology physician affiliated with The University of Texas Southwestern Medical Center. OpenAlex indexes 18 publications with 309 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2001 Inwood Rd Fl 8
Dallas, TX 75390
Telephone
214-645-2800Registry record last updated 30 May 2019.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year20231 payment
- Pharming Healthcare, Inc.Program year20221 payment
- GlaxoSmithKline, LLC.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
34.1%Folate Analog Metabolic Inhibitor9.6%Methotrexate100%Part D≥44 patientsTNF inhibitor7.6%Enbrel Sureclick47%Humira(Cf) Pen39%Humira14%Part D<11 patients+ 6 more classes in this area
Nervous system
22.2%Gabapentinoids7.9%Gabapentin68%Pregabalin32%Part D≥19 patientsNonsteroidal Anti-inflammatory Drug5%Meloxicam83%Ibuprofen17%Part D<11 patients+ 5 more classes in this area
Metabolism & gastrointestinal
17.8%Corticosteroid9.5%Prednisone100%Part D≥55 patientsAminosalicylate3.6%Sulfasalazine Dr63%Sulfasalazine37%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Toto, MD
The University of Texas Southwestern Medical Center
Abhimanyu Garg, MD
The University of Texas Southwestern Medical Center
Jing Chen, MD
The University of Texas Southwestern Medical Center
Raksha Jain, MD
The University of Texas Southwestern Medical Center
David Felson, MD
Boston University
Marc Hochberg, MD
University of Maryland School of Medicine
Philip Mease, MD
Michelle Petri, MD
Johns Hopkins University School of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”